|
|
Substance Name: Bortezomib [USAN:INN:BAN]
RN: 179324-69-7
UNII: 69G8BD63PP
InChIKey: GXJABQQUPOEUTA-RDJZCZTQSA-N
Notes
- A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA.
- A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA.
NCI: A dipeptide boronic acid analogue with antineoplastic activity. Bortezomib reversibly inhibits the 26S proteasome, a large protease complex that degrades ubiquinated proteins. By blocking the targeted proteolysis normally performed by the proteasome, bortezomib disrupts various cell signaling pathways, leading to cell cycle arrest, apoptosis, and inhibition of angiogenesis. Specifically, the agent inhibits nuclear factor (NF)-kappaB, a protein that is constitutively activated in some cancers, thereby interfering with NF-kappaB-mediated cell survival, tumor growth, and angiogenesis. In vivo, bortezomib delays tumor growth and enhances the cytotoxic effects of radiation and chemotherapy. (NCI Thesaurus)
Molecular Formula
- C19-H25-B-N4-O4
Molecular Weight
- 384.2415
Classification Codes
- Antineoplastic Agents
- Enzyme Inhibitors
- Protease Inhibitors
- Treatment of Multiple Cancers, Including Multiple Myeloma, Chroniclymphocytic Leukemia, Non-Hodgkins Lymphoma, and Pancreatic, Colon, Lung, and Prostate Cancers (Proteasome Inhibitor)
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Bortezomib
- Bortezomib [USAN:INN:BAN]
MeSH Heading
- Bortezomib
Synonyms
- ((1R)-3-Methyl-1-(((2S)-3-phenyl-2-((pyrazinylcarbonyl)amino)propanoyl)amino)butyl)boronic acid
- Boronic acid, ((1R)-3-methyl-1-(((2S)-1-oxo-3-phenyl-2-((pyrazinylcarbonyl)amino)propyl)amino)butyl)-
- Bortezomib
- HSDB 7666
- LDP 341
- LDP-341
- MG 341
- MLN-341
- N-((1S)-1-Benzyl-2-(((1R)-1-(dihydroxyboranyl)-3-methylbutyl)amino)-2-oxoethyl)pyrazinecarboxamide
- NSC 681239
- PS 341
- PS 341 (pharmaceutical)
- PS-341
- UNII-69G8BD63PP
- Velcade
Systematic Names
- Boronic acid, ((1R)-3-methyl-1-(((2S)-1-oxo-3-phenyl-2-((pyrazinylcarbonyl)amino)propyl)amino)butyl)-
- Boronic acid, (3-methyl-1-((1-oxo-3-phenyl-2-((pyrazinylcarbonyl)amino)propyl)amino)butyl)-, (S-(R*,S*))-
- N-((1S)-1-benzyl-2-(((1R)-1-(dihydroxyboranyl)-3-methylbutyl)amino)2-oxoethylpyrazinecarboxamide
Registry Numbers
CAS Registry Number
- 179324-69-7
FDA UNII
- 69G8BD63PP
Other Registry Number
- 197730-97-5
System Generated Number
- 0179324697